Related Experiment Video
Updated: Mar 9, 2026
06:51
Author Spotlight: Development of a Minimally Invasive Large-Animal Model for Reliable and Reproducible Cardiovascular Research
Published on: October 20, 2023
1.8K
Hypertrophic cardiomyopathy with aortic dilation: a novel observation
Rayan Yousefzai1, Anushree Agarwal1, M Fuad Jan1
1Aurora Cardiovascular Services, Aurora Sinai/Aurora St. Luke's Medical Centers, University of Wisconsin School of Medicine and Public Health, 2801 W. Kinnickinnic River Parkway, Ste. 840, Milwaukee, WI, USA.
European Heart Journal. Cardiovascular Imaging
|December 28, 2016
Summary
This study found that 9.0% of patients with hypertrophic cardiomyopathy (HCM) also have aortic dilation. This highlights a potential link between these two cardiovascular conditions that warrants further investigation.
Area of Science:
- Cardiology
- Genetics
- Vascular Medicine
Background:
- Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiovascular disease.
- Aortic dilation is a condition that can run in families.
- Data on the prevalence of aortic dilation in HCM patients is limited.
Purpose of the Study:
- To determine the prevalence of aortic dilation in patients diagnosed with hypertrophic cardiomyopathy.
- To investigate the association between aortic dilation and HCM.
Main Methods:
- Observational retrospective study.
- Included 201 patients referred to an HCM center between January 2011 and March 2014.
- Aortic dilation defined using American Society of Echocardiography and European Association of Cardiovascular Imaging guidelines.
Main Results:
- 18 out of 201 (9.0%) HCM patients met the criteria for aortic dilation.
- Patients with aortic dilation were more likely to be male, less likely to be hypertensive, and had larger left ventricle diameter and more aortic valve regurgitation.
- Mean ascending aorta diameter was 4.0 cm in males and 3.8 cm in females; mean sinuses of Valsalva diameter was 4.2 cm in males and 3.8 cm in females.
Conclusions:
- A novel observation of 9.0% prevalence of aortic dilation in HCM patients is reported.
- Further research is needed to understand the genetic and pathophysiological basis of this association.
- Clinical implications of aortic dilation in HCM patients require further study in larger cohorts.
Related Concept Videos
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
602
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
602
01:30Cardiomyopathy II: Dilated Cardiomyopathy
695
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
695
01:22Aortic Regurgitation II: Clinical Features and Diagnostic Tests
731
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
731
01:29Heart Failure II: Pathophysiology
1.2K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
01:29Cardiomyopathy V: Interprofessional Care
566
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
566
01:25Cardiomyopathy I: Introduction and Classification
741
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
741